FEDEX CORP (FDX)       172.33  +0.42 (+0.24%)

172.33  +0.42 (+0.24%)

US31428X1063 - Common Stock - After market: 172.01 -0.32 (-0.19%)


Fundamental Rating

4

Overall FDX gets a fundamental rating of 4 out of 10. We evaluated FDX against 18 industry peers in the Air Freight & Logistics industry. FDX scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. A decent growth rate in combination with a cheap valuation! Better keep an eye on FDX.




Profitability

Profitability Rating

1

FDX has a Piotroski-F score of 6.00. This indicates an average health and profitability for FDX.
FDX's Return On Assets of 4.18% is worse than the rest of the industry. The industry average Return On Assets is 13.15%.

FDX's Return On Equity of 14.28% is worse than the rest of the industry. The industry average Return On Equity is 34.19%.
FDX's Profit Margin of 3.79% is worse than the rest of the industry. The industry average Profit Margin is 9.65%. 80% of the industry peers have a better Profit Margin.
VS Industry

ROA (4.18%) VS Industry: 23% outperformed.

-77.58
24.08

ROE (14.28%) VS Industry: 40% outperformed.

0.64
65.94

Profit Margin (3.79%) VS Industry: 20% outperformed.

1.44
30.55

Valuation

Valuation Rating

7

The Price/Earnings Ratio is 8.73, which indicates a very decent valuation of FDX.
With a Forward Price/Earnings Ratio of 9.44, the valuation of FDX can be described as very reasonable.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry price book ratio of 2.00, FDX is valued rather cheaply

When comparing the Enterprise Value to EBITDA ratio of FDX to the average industry ratio of 6.91, FDX is valued rather cheaply.
FDX's Price/Earning Ratio is in line with the industry average which is at 11.34.
When comparing the current price to the book value of FDX, we can conclude it is valued correctly. It is trading at 1.78 times its book value.
VS Industry

Price/Earnings (8.73) VS Industry: 53% outperformed.

144.90
4.24

Price/Book (1.78) VS Industry: 64% outperformed.

9.05
0.30

Enterprise Value/ EBITDA (5.62) VS Industry: 80% outperformed.

37.84
4.30

Growth

Growth Rating

5

FDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.60%, which is quite good.
FDX shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 10.93% yearly.
Based on estimates for the next 5 years, FDX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.94% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

The Revenue has been growing slightly by 9.36% in the past year.
The Revenue has been growing slightly by 9.16% on average over the past 5 years.
Based on estimates for the next 5 years, FDX will show a small growth in Revenue. The Revenue will grow by 1.30% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS10.93% 9.98% 11.6% -29.13% -5.98% 3.13% 10.94%
Revenue9.16% 10.3% 9.36% 1.18% 1.56% 2.02% 1.3%

Health

Health Rating

5

FDX is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.32.
A Current Ratio of 1.42 indicates that FDX should not have too much problems paying its short term obligations.
A Quick Ratio of 1.38 indicates that FDX should not have too much problems paying its short term obligations.
FDX has a Quick Ratio comparable to the industry average, which is at 1.32.

FDX has an Altman-Z score of 2.41. This is not the best score and indicates that FDX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.41.
The Piotroski-F score of FDX is 6.00. This is a neutral score and indicates average health and profitability for FDX.
Compared to an average industry Debt to Equity Ratio of 0.69, FDX is requires more financing than its industry peers. 83% of its industry peers have a better Debt to Equity Ratio.
VS Industry

Debt/Equity (0.79) VS Industry: 17% outperformed.

1.05
0.00

Quick Ratio (1.38) VS Industry: 58% outperformed.

0.72
22.51

Current Ratio (1.42) VS Industry: 70% outperformed.

0.72
22.51

Altman-Z (2.41) VS Industry: 52% outperformed.

-3.91
8.55

Dividend

Dividend Rating

6

FDX's Dividend Yield is rather good when compared to the industry average which is at 0.86. FDX pays more dividend than 87% of the companies in the same industry.
24.85% of the earnings are spent on dividend by FDX. This is a low number and sustainable payout ratio.
FDX has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 2.60%, FDX has a reasonable but not impressive dividend return.

Compared to an average S&P500 Dividend Yield of 2.43, FDX has a dividend comparable with the average S&P500 company.
The dividend of FDX has a limited annual growth rate of 4.89%.
The Dividend Rate of FDX has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (2.6%) VS Industry: 87% outperformed.

0.83
3.33
FDX Daily chart

FEDEX CORP172.33

NYSE:FDX (12/9/2022, 7:04:00 PM)+0.42 (+0.24%)

After market: 172.01 -0.32 (-0.19%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Transportation
GICS Industry Air Freight & Logistics
Earnings (Last) 09-15 2022-09-15/amc Earnings (Next) 12-20 2022-12-20/amc
Ins Owners 5.7% Inst Owners 72.42%
Market Cap 44.84B Analysts 73.33
Valuation
PE 8.73 Fwd PE 9.44
PEG (NY) N/A PEG (5Y) 0.8
P/S 0.47 P/B 1.78
EV/EBITDA 5.62
Dividend
Dividend Yield 2.6% Dividend Growth 4.89%
DP 24.85% Ex-Date 09-01 2022-09-01 (1.15)
Growth
EPS 1Y 11.6% EPS 3Y 9.98%
EPS 5Y 10.93% EPS growth Q2Q -21.28%
EPS Next Y -29.13% EPS Next 2Y -5.98%
EPS Next 3Y 3.13% EPS Next 5Y 10.94%
Revenue growth 1Y 9.36% Revenue growth 3Y 10.3%
Revenue growth 5Y 9.16% Revenue growth Q2Q 5.63%
Revenue Next Year 1.18% Revenue Next 2Y 1.56%
Revenue Next 3Y 2.02% Revenue Next 5Y 1.3%
Health
Current Ratio 1.42 Quick Ratio 1.38
Altman-Z 2.41 F-Score 6
Debt/Equity 0.79 WACC 7.17%
ROIC/WACC 1.13
Profitability
ROA 4.18% ROE 14.28%
ROICexgc 8.13% ROIC 6.65%
PM 3.79% OM 6.64%
Asset Turnover 1.1

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA